Forge Biologics to Present at Chardan’s 5th Annual Genetic Medicines Manufacturing Summit

COLUMBUS, OHIO April 22, 2021 – Forge Biologics, a hybrid gene therapy contract manufacturing, and clinical stage therapeutic development company, […]

Read More… from Forge Biologics to Present at Chardan’s 5th Annual Genetic Medicines Manufacturing Summit

Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean

COLUMBUS, OHIO April 6, 2021 – Forge Biologics, a cGMP manufacturing and development company, announced today that Timothy J. Miller, […]

Read More… from Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean

FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

The FDA has granted Fast Track Designation, Rare Pediatric Disease Designation, and Orphan Drug Designation to FBX-101 for treatment of patients […]

Read More… from FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

VIDEO: Manufacturing Capabilities

We are passionate about serving our clients by providing the highest quality vector and leading the industry in technological advancements. […]

Read More… from VIDEO: Manufacturing Capabilities

“Building Better” Blog: Forge Biologics Spotlight

We are thrilled to have a spotlight in National Venture Capital Association‘s (NVCA) Building Better blog series alongside Molly (McCartin) Bonakdarpour of Drive […]

Read More… from “Building Better” Blog: Forge Biologics Spotlight